Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Lofexidine on Stress and Craving in OUD
NCT03718065Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jun 2019
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lofexidine in opioid use disorder (OUD), sponsored by Medical University of South Carolina. Started Jun 2019; status: completed.
02
Drugs
lofexidine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03718065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03718065.